10 likes | 84 Views
This study analyzes the survival rates of cirrhosis patients treated with TACE, RFA, or HR and compares their outcomes over time. Results show varying effectiveness among the treatments.
E N D
JIS 1 Child-Pugh A / stage II JIS 1 Child-Pugh B / stage I A B 100 100 HR (n=1405) HR (n=18) 80 80 77% 60 60 RFA (n=32) RFA (n=141) 53% Patient’s survival (%) Patient’s survival (%) 45% 40 40 TACE (n=422) HR vs. RFA: P=0.35 HR vs. TACE: P=0.18 RFA vs. TACE: P=0.67 HR vs. RFA: P=0.04 HR vs. TACE: P<0.01 RFA vs. TACE: P=0.07 20 20 22% TACE (n=44) 0 0 2 4 2 4 0 1 3 5 0 1 3 5 Years after treatment Years after treatment